cloxacillin has been researched along with cefazolin in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (16.22) | 18.7374 |
1990's | 5 (13.51) | 18.2507 |
2000's | 6 (16.22) | 29.6817 |
2010's | 10 (27.03) | 24.3611 |
2020's | 10 (27.03) | 2.80 |
Authors | Studies |
---|---|
Apiwattanakul, N; Endou, H; Jariyawat, S; Kanai, Y; Sekine, T; Sophasan, S; Takeda, M | 1 |
Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Martin, RR; Vance, P; Wallace, RJ; Weissfeld, A | 1 |
Inoue, M; Mitsuhashi, S; Okubo, T | 1 |
Fallara, A; Ravaoarinoro, M; Toma, E | 1 |
Claessens, H; Myny, P; Paeme, G; Van Meirhaeghe, J; Verdonk, R; Verschraegen, G | 1 |
Igari, J; Kakazu, R; Nakasone, I; Shimoji, K; Taira, K; Uezu, N | 1 |
Kawasaki, K; Ohnogi, J | 1 |
Jackson, RW | 1 |
Davies, RA; Masters, RG; Newton, G; Saginur, R; Struthers, C; Walley, VM | 1 |
Cerisier, A; Chevalier, P; Cucherat, M; Da Costa, A; Delahaye, F; Isaaz, K; Kirkorian, G; Touboul, P | 1 |
Heller, DN; Ngoh, MA | 1 |
Barkema, HW; Sampimon, OC; Schukken, YH; Sol, J | 1 |
Guerra, JM; Varona, JF | 1 |
Khangura, S; Kissoon, N; Kodeeswaran, T; Wallace, J | 1 |
Chuckpaiwong, B; Phoompoung, S | 1 |
Bai, AD; Bell, CM; Burry, L; Chiu, A; Fernandes, T; Fernando, E; Morris, AM; Raybardhan, S; Ricciuto, DR; Science, M; Showler, A; Steinberg, M; Tomlinson, G | 1 |
Chatfield, M; Cheng, AC; Davis, JS; Fowler, VG; Howden, BP; Lipman, J; Lye, D; Nelson, J; O'Sullivan, M; Paterson, DL; Robinson, JO; Tong, SY; Van Hal, S; Yahav, D | 1 |
Hulin, A; Khoudour, N; Legrand, T; Tournier, N; Vodovar, D | 1 |
Eumkeb, G; Hobbs, G; Pimchan, T; Srisawat, R; Teethaisong, Y | 1 |
Butler-Laporte, G; Cheng, MP; Lawandi, A; Lee, TC; Paquette, K | 1 |
Burdet, C; Duval, X; Esposito-Farèse, M; Ferry, T; Grall, N; Le Moing, V; Lescure, FX; Linard, M; Loubet, P; Massias, L; Mentré, F; Quintin, C; Tattevin, P; Vandenesch, F; Vindrios, W; Wolff, M | 1 |
Anagnostou, NA; Andresen, DN; Archuleta, S; Bak, N; Cass, A; Chatfield, MD; Cheng, AC; Davies, J; Davis, JS; Dotel, R; Ferguson, PE; Foo, H; Fowler, VG; Ghosh, N; Gray, TJ; Guy, SD; Holmes, NE; Howden, BP; Johnson, SA; Kalimuddin, S; Lye, DC; McBride, S; McKew, GL; Meagher, N; Nelson, J; O'Sullivan, MVN; Paterson, DL; Paul, M; Price, DJ; Ralph, AP; Roberts, MA; Robinson, JO; Rogers, BA; Runnegar, N; Smith, S; Sud, A; Tong, SYC; Tramontana, AR; van Hal, SJ; Walls, GB; Warner, MS; Yahav, D; Young, BE | 1 |
Bellouard, R; Boutoille, D; Deschanvres, C; Deslandes, G; Dubée, V; Gaborit, BJ; Gregoire, M; Lakhal, K; Le Turnier, P; Lecomte, R; Leroy, AG; Talarmin, JP | 1 |
Alleman, L; Barret, A; Guerpillon, B; Jaouen, AC; Leyssene, D; Vareil, MO; Vinclair, C; Wille, H | 1 |
Bai, AD; Findlater, A; Irfan, N; Loeb, M; Singhal, N | 1 |
Almirante, B; Fernández-Hidalgo, N; González-López, JJ; Larrosa, MN; Pigrau, C; Puig-Asensio, M; Rodríguez-Pardo, D; Suanzes, P; Willekens, R | 1 |
Cass, A; Davies, J; Davis, JS; Johnson, SA; Legg, A; Meagher, N; Roberts, JA; Roberts, MA; Scheetz, MH; Tong, SYC | 1 |
Alikhani, MY; Arabestani, MR; Mirzaei, R; Sedighi, I; Yousefimashouf, R | 1 |
Dale, H; Fenstad, AM; Furnes, O; Gjertsen, JE; Hallan, G; Leta, T; Lie, SA; Pawloy, K | 1 |
Bergin, S; De, PP; Hon, PY; Lye, DC; Mok, HT; Teng, CB; Vasoo, S | 1 |
Alonso-Menchén, D; Álvarez-Uría, A; Angulo-Lara, B; Boix-Palop, L; de Alarcón, A; Fariñas, MDC; Goenaga, MA; Gutiérrez-Carretero, E; Herrera-Hidalgo, L; López-Cortés, LE; Luque-Marquez, R; Miró, JM; Muñoz, P | 1 |
3 review(s) available for cloxacillin and cefazolin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Antibiotic Prophylaxis; Cefazolin; Cloxacillin; Double-Blind Method; Female; Floxacillin; Humans; Incidence; Male; Middle Aged; Pacemaker, Artificial; Penicillin G; Prospective Studies; Randomized Controlled Trials as Topic; Sepsis; Surgical Wound Infection; Treatment Outcome | 1998 |
Factors associated with cure after therapy of clinical mastitis caused by Staphylococcus aureus.
Topics: Ampicillin; Animals; Antibiotics, Antitubercular; beta-Lactam Resistance; Cattle; Cefazolin; Cephalosporins; Cloxacillin; Colistin; Double-Blind Method; Female; Mastitis, Bovine; Milk; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim | 2000 |
7 trial(s) available for cloxacillin and cefazolin
Article | Year |
---|---|
Flucloxacillin compared with cefazolin in short-term prophylaxis for clean orthopedic surgery.
Topics: Adolescent; Aged; Cefazolin; Cloxacillin; Double-Blind Method; Female; Floxacillin; Humans; Male; Middle Aged; Orthopedics; Premedication; Prospective Studies; Random Allocation; Surgical Wound Infection | 1989 |
Factors associated with cure after therapy of clinical mastitis caused by Staphylococcus aureus.
Topics: Ampicillin; Animals; Antibiotics, Antitubercular; beta-Lactam Resistance; Cattle; Cefazolin; Cephalosporins; Cloxacillin; Colistin; Double-Blind Method; Female; Mastitis, Bovine; Milk; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim | 2000 |
CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
Topics: Anti-Bacterial Agents; Australia; beta-Lactams; Cefazolin; Clinical Protocols; Cloxacillin; Daptomycin; Drug Therapy, Combination; Floxacillin; Humans; Israel; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; New Zealand; Research Design; Singapore; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin | 2016 |
Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Cloxacillin; Daptomycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Multicenter Studies as Topic; Quebec; Randomized Controlled Trials as Topic; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Treatment Outcome | 2018 |
Efficacy of cloxacillin versus cefazolin for methicillin-susceptible
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefazolin; Clinical Protocols; Cloxacillin; Humans; Staphylococcal Infections; Staphylococcus aureus | 2018 |
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Cloxacillin; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Floxacillin; Follow-Up Studies; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Treatment Failure; Vancomycin | 2020 |
Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Cloxacillin; Drug-Related Side Effects and Adverse Reactions; Humans; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2023 |
28 other study(ies) available for cloxacillin and cefazolin
Article | Year |
---|---|
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
Topics: Animals; Anion Transport Proteins; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Cell Survival; Cephaloridine; Cephalosporins; In Vitro Techniques; Kidney; Kinetics; Oocytes; p-Aminohippuric Acid; Penicillin G; Rats; Recombinant Proteins; Xenopus laevis | 1999 |
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Beta-lactamase production and resistance to beta-lactam antibiotics in Nocardia.
Topics: Ampicillin; beta-Lactamases; Carbenicillin; Cefazolin; Cephalosporinase; Cephalosporins; Cloxacillin; Nocardia; Penicillin G; Penicillin Resistance; Penicillinase; Penicillins | 1978 |
Antibacterial activity of combinations of cefazolin and semisynthetic penicillins.
Topics: Cefazolin; Cephalosporins; Cloxacillin; Dicloxacillin; Dose-Response Relationship, Drug; Drug Synergism; Escherichia; Penicillin Resistance; Proteus; Regression Analysis | 1975 |
Inducible beta-lactamases in clinical isolates of non-aeruginosa Pseudomonas.
Topics: beta-Lactamases; Cefazolin; Chloromercuribenzoates; Ciprofloxacin; Clavulanic Acids; Cloxacillin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Edetic Acid; Humans; Hydrolysis; Imipenem; Isoelectric Point; Molecular Weight; Norfloxacin; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Spectrophotometry | 1992 |
[In vitro susceptibilities of clinical isolates of Staphylococcus aureus].
Topics: Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefmenoxime; Cefmetazole; Cloxacillin; Drug Resistance, Microbial; Methicillin; Staphylococcus aureus | 1988 |
Nontoxic concentration of antibiotics for intravitreal use--evaluated by human in-vitro ERG.
Topics: Anti-Bacterial Agents; Cefazolin; Cloxacillin; Electroretinography; Fosfomycin; Gentamicins; Humans; In Vitro Techniques; Oscillometry; Penicillins; Procaine; Sulbenicillin; Vitreous Body | 1988 |
The septic knee--arthroscopic treatment.
Topics: Arthritis, Infectious; Arthroscopy; Bacterial Infections; Cefazolin; Cloxacillin; Follow-Up Studies; Humans; Intraoperative Complications; Knee Joint; Penicillins; Polyethylene Glycols; Surface-Active Agents; Therapeutic Irrigation | 1985 |
Bacterial pericarditis after heart transplantation: successful management of two cases with catheter drainage and antibiotics.
Topics: Adult; Anti-Bacterial Agents; Cardiac Catheterization; Cefazolin; Cloxacillin; Drainage; Heart Transplantation; Humans; Male; Middle Aged; Pericarditis; Postoperative Complications; Rifampin; Staphylococcal Infections | 1996 |
Electrospray ionization and tandem ion trap mass spectrometry for the confirmation of seven beta-lactam antibiotics in bovine milk.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Cefazolin; Cephalosporins; Cephapirin; Chromatography, Liquid; Cloxacillin; Female; Food Contamination; Mass Spectrometry; Milk; Penicillin G | 1998 |
[Tricuspid valve endocarditis in a nonaddicted patient without predisposing myocardiopathy].
Topics: Anti-Bacterial Agents; Cefazolin; Cloxacillin; Echocardiography; Endocarditis, Bacterial; Follow-Up Studies; Humans; Male; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tricuspid Valve | 2004 |
Management of cellulitis in a pediatric emergency department.
Topics: Academic Medical Centers; Adjuvants, Pharmaceutic; Administration, Oral; Adolescent; Anti-Bacterial Agents; British Columbia; Case-Control Studies; Cefazolin; Cellulitis; Cephalexin; Child; Child, Preschool; Cloxacillin; Emergency Service, Hospital; Female; Humans; Infant; Infusions, Intravenous; Male; Patient Admission; Probenecid; Retrospective Studies; Staphylococcus aureus; Streptococcus pyogenes | 2007 |
Success rates of first-line antibiotics for culture-negative sub-acute and chronic septic arthritis.
Topics: Adult; Anti-Bacterial Agents; Arthritis, Infectious; Cefazolin; Clindamycin; Cloxacillin; Debridement; Drainage; Female; Humans; Male; Middle Aged; Retrospective Studies; Vancomycin | 2014 |
Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cefazolin; Cloxacillin; Cohort Studies; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Treatment Outcome | 2015 |
Simultaneous Determination of Eight β-Lactam Antibiotics, Amoxicillin, Cefazolin, Cefepime, Cefotaxime, Ceftazidime, Cloxacillin, Oxacillin, and Piperacillin, in Human Plasma by Using Ultra-High-Performance Liquid Chromatography with Ultraviolet Detection
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Cloxacillin; Drug Monitoring; Humans; Oxacillin; Piperacillin; Ultraviolet Rays | 2016 |
Boesenbergia rotunda (L.) Mansf. extract potentiates the antibacterial activity of some β-lactams against β-lactam-resistant staphylococci.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cloxacillin; Drug Resistance, Bacterial; Drug Synergism; Humans; Male; Microbial Sensitivity Tests; Plant Extracts; Rats; Staphylococcal Infections; Staphylococcus; Zingiberaceae | 2018 |
Should we reconsider cefazolin for treating staphylococcal meningitis? A retrospective analysis of cefazolin and cloxacillin cerebrospinal fluid levels in patients treated for staphylococcal meningitis.
Topics: Aged; Anti-Bacterial Agents; Cefazolin; Chromatography, Liquid; Cloxacillin; Female; Humans; Male; Mass Spectrometry; Meningitis, Bacterial; Middle Aged; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2020 |
Prolonged cefazolin course for treatment of methicillin susceptible staphylococcus species infections and the impact on the emergence of multidrug-resistant bacteria during cloxacillin shortage.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bone Diseases, Infectious; Carbapenem-Resistant Enterobacteriaceae; Cefazolin; Cloxacillin; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Female; Humans; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2021 |
Cefazolin versus cloxacillin as definitive antibiotic therapy for methicillin-susceptible Staphylococcus aureus spinal epidural abscess: a retrospective cohort study.
Topics: Aged; Anti-Bacterial Agents; Canada; Cefazolin; Cloxacillin; Epidural Abscess; Female; Humans; Male; Methicillin; Middle Aged; Recurrence; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2021 |
Empirical use of β-lactam/β-lactamase inhibitor combinations does not increase mortality compared with cloxacillin and cefazolin in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-weighted cohort study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactams; Cefazolin; Cloxacillin; Cohort Studies; Humans; Lactams; Methicillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2022 |
The issue beyond resistance: Methicillin-resistant Staphylococcus epidermidis biofilm formation is induced by subinhibitory concentrations of cloxacillin, cefazolin, and clindamycin.
Topics: Anti-Bacterial Agents; Biofilms; Cefazolin; Clindamycin; Cloxacillin; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2022 |
No difference in risk of revision due to infection between clindamycin and cephalosporins as antibiotic prophylaxis in cemented primary total knee replacements: a report from the Norwegian Arthroplasty Register 2005-2020.
Topics: Antibiotic Prophylaxis; Arthroplasty, Replacement, Knee; Cefazolin; Cephalosporins; Cephalothin; Clindamycin; Cloxacillin; Humans; Prosthesis-Related Infections; Reoperation | 2023 |
Treatment outcomes with benzylpenicillin and non-benzylpenicillin antibiotics, and the performance of the penicillin zone-edge test versus molecular detection of blaZ in penicillin-susceptible Staphylococcus aureus (PSSA) bacteraemia.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Cloxacillin; Humans; Microbial Sensitivity Tests; Penicillin G; Penicillinase; Penicillins; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2023 |
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Cloxacillin; Endocarditis, Bacterial; Humans; Prospective Studies; Recurrence; Renal Insufficiency; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2023 |